{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T20:31:40Z","timestamp":1792614700073,"version":"4.5.0"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T00:00:00Z","timestamp":1443225600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neural Transm"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1007\/s00702-015-1463-8","type":"journal-article","created":{"date-parts":[[2015,9,26]],"date-time":"2015-09-26T04:07:01Z","timestamp":1443240421000},"page":"19-30","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Therapy-resistant symptoms in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"123","author":[{"given":"Ruxandra Julia","family":"Vorovenci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Biundo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Antonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,9,26]]},"reference":[{"issue":"5","key":"1463_CR1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1001\/archneur.56.5.595","volume":"56","author":"D Aarsland","year":"1999","unstructured":"Aarsland D, Larsen JP, Cummins JL, Laake K (1999) Prevalence and clinical correlates of psychotic symptoms in Parkinson disease: a community-based study. Arch Neurol 56(5):595\u2013601","journal-title":"Arch Neurol"},{"issue":"12","key":"1463_CR2","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/archneur.61.12.1906","volume":"61","author":"D Aarsland","year":"2004","unstructured":"Aarsland D, Andersen K, Larsen JP et al (2004) The rate of cognitive decline in Parkinson\u2019s disease. Arch Neurol 61(12):1906\u20131911","journal-title":"Arch Neurol"},{"issue":"12","key":"1463_CR3","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1212\/WNL.0b013e3181f39d0e","volume":"75","author":"D Aarsland","year":"2010","unstructured":"Aarsland D, Bronnick K, Williams-Gray C et al (2010) Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 75(12):1062\u20131069","journal-title":"Neurology"},{"issue":"4","key":"1463_CR4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11910-011-0203-1","volume":"11","author":"D Aarsland","year":"2011","unstructured":"Aarsland D, Br\u00f8nnick K, Fladby T (2011) Mild cognitive impairment in Parkinson\u2019s disease. Curr Neurol Neurosci Rep 11(4):371\u2013378","journal-title":"Curr Neurol Neurosci Rep"},{"key":"1463_CR5","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000326617","volume":"89","author":"F Acar","year":"2011","unstructured":"Acar F, Acar G, Bir LS, Gedik B, O\u011fuzhano\u011flu A (2011) Deep Brain Stimulation of the Pedunculopontine Nucleus in a Patient with Freezing of Gait. Stereotact Funct Neurosurg 89:214\u2013219","journal-title":"Stereotact Funct Neurosurg"},{"issue":"1-2","key":"1463_CR500","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jns.2015.06.037","volume":"356","author":"H Alzahrani","year":"2015","unstructured":"Alzahrani H, Venneri A (2015) Cognitive and neuroanatomical correlates of neuropsychiatric symptoms in Parkinson's disease: A systematic review. J Neurol Sci 356(1-2):32\u201344","journal-title":"J Neurol Sci"},{"issue":"6","key":"1463_CR6","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.parkreldis.2015.03.028","volume":"21","author":"M Amboni","year":"2015","unstructured":"Amboni M, Stocchi F, Abbruzzese G et al (2015) Prevalence and associated features of self-reported freezing of gait in Parkinson disease: the DEEP FOG study. Parkinsonism Relat Disord 21(6):644\u2013649","journal-title":"Parkinsonism Relat Disord"},{"issue":"9","key":"1463_CR7","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1212\/WNL.0b013e318285c16d","volume":"80","author":"A Antonini","year":"2013","unstructured":"Antonini A, Albin RL (2013) Dopaminergic treatment and nonmotor features of Parkinson disease: the horse lives. Neurology 80(9):784\u2013785","journal-title":"Neurology"},{"key":"1463_CR8","doi-asserted-by":"crossref","unstructured":"Antonini et al (2015) Effects of rotigotine transdermal patch in patients with Parkinson\u2019s disease presenting with non-motor symptoms\u2014results of a double-blind, randomized, placebo-controlled trial. Eur J Neurol [Epub ahead of print]","DOI":"10.1111\/ene.12757"},{"issue":"3","key":"1463_CR9","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000324907","volume":"89","author":"T Asahi","year":"2011","unstructured":"Asahi T, Taguchi Y, Hayashi N, Hamada H, Dougu N, Takashima S, Tanaka K, Endo S (2011) Bilateral subthalamic\u00a0deep\u00a0brain\u00a0stimulation\u00a0for\u00a0camptocormia\u00a0associated with\u00a0Parkinson\u2019s disease. Stereotact Funct Neurosurg 89(3):173\u2013177","journal-title":"Stereotact Funct Neurosurg"},{"issue":"6","key":"1463_CR10","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1136\/jnnp-2012-303135","volume":"84","author":"M Asahina","year":"2013","unstructured":"Asahina M, Vichayanrat E, Low DA, Iodice V, Mathias CJ (2013) Autonomic dysfunction in parkinsonian disorders: assessment and pathophysiology. J Neurol Neurosurg Psychiatr 84(6):674\u2013680","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"4","key":"1463_CR11","doi-asserted-by":"crossref","first-page":"6819","DOI":"10.3390\/s140406819","volume":"14","author":"C Azevedo Coste","year":"2014","unstructured":"Azevedo Coste C, Sijobert B, Pissard-Gibollet R, Pasquier M, Espiau B, Geny C (2014) Detection of freezing of gait in parkinson disease: preliminary results. Sensors (Basel) 14(4):6819\u20136827","journal-title":"Sensors (Basel)"},{"key":"1463_CR12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1212\/01.wnl.0000171857.09079.9f","volume":"65","author":"SN Azher","year":"2005","unstructured":"Azher SN, Jankovic J (2005) Camptocormia: pathogenesis, classification and response to therapy. Neurology 65:355\u2013359","journal-title":"Neurology"},{"issue":"2","key":"1463_CR13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1007\/s00415-013-7199-1","volume":"261","author":"MT Barbe","year":"2014","unstructured":"Barbe MT, Amarell M, Snijders AH et al (2014) Gait and upper limb variability in Parkinson\u2019s disease patients with and without freezing of gait. J Neurol 261(2):330\u2013342","journal-title":"J Neurol"},{"issue":"6","key":"1463_CR14","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(10)70106-X","volume":"9","author":"P Barone","year":"2010","unstructured":"Barone P et al (2010) Pramipexole for the treatment of depressive symptoms in patients with Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 9(6):573\u2013580","journal-title":"Lancet Neurol"},{"issue":"14","key":"1463_CR15","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1002\/mds.23919","volume":"26","author":"P Barone","year":"2011","unstructured":"Barone P, Aarsland D, Burn D, Emre M, Kulisevsky J, Weintraub D (2011) Cognitive impairment in nondemented Parkinson\u2019s disease. Mov Disord 26(14):2483\u20132495","journal-title":"Mov Disord"},{"issue":"3","key":"1463_CR16","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/mds.870110318","volume":"11","author":"KJ Bharucha","year":"1996","unstructured":"Bharucha KJ, Sethi KD (1996) Complex movement disorders induced by fluoxetine. Mov Disord 11(3):324\u2013326","journal-title":"Mov Disord"},{"issue":"4","key":"1463_CR17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s00702-013-1004-2","volume":"120","author":"R Biundo","year":"2013","unstructured":"Biundo R, Weis L, Pilleri M et al (2013) Diagnostic and screening power of neuropsychological testing in detecting mild cognitive impairment in Parkinson\u2019s disease. J Neural Transm 120(4):627\u2013633","journal-title":"J Neural Transm"},{"issue":"4","key":"1463_CR18","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.parkreldis.2014.01.009","volume":"20","author":"R Biundo","year":"2014","unstructured":"Biundo R, Weis L, Facchini S et al (2014) Cognitive profiling of Parkinson disease patients with mild cognitive impairment and dementia. Parkinsonism Relat Disord 20(4):394\u2013399","journal-title":"Parkinsonism Relat Disord"},{"key":"1463_CR19","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1136\/jnnp.2006.087908","volume":"77","author":"F Bloch","year":"2006","unstructured":"Bloch F, Houeto JL, Tezenas du Montcel S, Bonneville F, Etchepare F, Welter ML, Rivaud-Pechoux S, Hahn-Barma V, Maisonobe T, Behar C, Lazennec JY, Kurys E, Arnulf I, Bonnet AM, Agid Y (2006) Parkinson\u2019s disease with camptocormia. J Neurol Neurosurg Psychiatry 77:1223\u20131228","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"1463_CR20","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1001\/archneur.60.12.1745","volume":"60","author":"NI Bohnen","year":"2003","unstructured":"Bohnen NI, Kaufer DI, Ivanco LS et al (2003) Cortical cholinergic function is more severely affected in parkinsonian dementia than in Alzheimer disease: an in vivo positron emission tomographic study. Arch Neurol 60(12):1745\u20131748","journal-title":"Arch Neurol"},{"issue":"14","key":"1463_CR21","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/mds.21694","volume":"22","author":"L Bonanni","year":"2007","unstructured":"Bonanni L, Thomas A, Varanese S, Scorrano V, Onofrj M (2007) Botulinum toxin treatment of lateral axial dystonia in Parkinsonism. Mov Disord 22(14):2097\u20132103","journal-title":"Mov Disord"},{"issue":"2","key":"1463_CR22","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40263-014-0221-z","volume":"29","author":"A Boyle","year":"2015","unstructured":"Boyle A, Ondo W (2015) Role of apomorphine in the treatment of Parkinson\u2019s disease. CNS drugs 29(2):83\u201389","journal-title":"CNS drugs"},{"issue":"5","key":"1463_CR23","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s11910-010-0127-1","volume":"10","author":"N Browner","year":"2010","unstructured":"Browner N, Giladi N (2010) What can we learn from freezing of gait in Parkinson\u2019s disease? Curr Neurol Neurosci Rep 10(5):345\u2013351","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"1463_CR24","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1136\/jnnp.2005.081711","volume":"77","author":"DJ Burn","year":"2006","unstructured":"Burn DJ, Rowan EN, Allan LM, Molloy S, O\u2019brien JT, Mckeith IG (2006) Motor subtype and cognitive decline in Parkinson\u2019s disease, Parkinson\u2019s disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatr 77(5):585\u2013589","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"9","key":"1463_CR25","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1002\/mds.25925","volume":"29","author":"A Castrioto","year":"2014","unstructured":"Castrioto A, Piscicelli C, P\u00e9rennou D, Krack P, Deb\u00fb B (2014) The pathogenesis of Pisa syndrome in Parkinson\u2019s disease. Mov Disord 29(9):1100\u20131107","journal-title":"Mov Disord"},{"issue":"3","key":"1463_CR26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.parkreldis.2014.12.019","volume":"21","author":"FC Chang","year":"2015","unstructured":"Chang FC, Tsui DS, Mahant N et al (2015) 24\u00a0h Levodopa-carbidopa intestinal gel may reduce falls and \u201cunresponsive\u201d freezing of gait in Parkinson\u2019s disease. Parkinsonism Relat Disord 21(3):317\u2013320","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"1463_CR27","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S1474-4422(09)70068-7","volume":"8","author":"KR Chaudhuri","year":"2009","unstructured":"Chaudhuri KR, Schapira AH (2009) Non-motor symptoms of Parkinson\u2019s disease: dopaminergic pathophysiology and treatment. Lancet Neurol 8(5):464\u2013474","journal-title":"Lancet Neurol"},{"issue":"3","key":"1463_CR28","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.parkreldis.2014.12.031","volume":"21","author":"KR Chaudhuri","year":"2015","unstructured":"Chaudhuri KR, Sauerbier A, Rojo JM, Sethi K, Schapira AH, Brown RG et al (2015) The burden of non-motor symptoms in Parkinson\u2019s disease using a self-completed non-motor questionnaire: a simple grading system. Parkinsonism Relat Disord 21(3):287\u2013291","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"1463_CR29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-0033-1358367","volume":"34","author":"MR Ciucci","year":"2013","unstructured":"Ciucci MR, Grant LM, Rajamanickam ES et al (2013) Early identification and treatment of communication and swallowing deficits in Parkinson disease. Semin Speech Lang 34(3):185\u2013202","journal-title":"Semin Speech Lang"},{"issue":"1","key":"1463_CR30","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3233\/JPD-130221","volume":"4","author":"RG Cohen","year":"2014","unstructured":"Cohen RG, Klein KA, Nomura M et al (2014) Inhibition, executive function, and freezing of gait. J Parkinsons Dis 4(1):111\u2013122","journal-title":"J Parkinsons Dis"},{"issue":"1","key":"1463_CR31","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.neuroimage.2007.03.071","volume":"37","author":"MW Cole","year":"2007","unstructured":"Cole MW, Schneider W (2007) The cognitive control network: integrated cortical regions with dissociable functions. Neuroimage 37(1):343\u2013360","journal-title":"Neuroimage"},{"issue":"1\u20132","key":"1463_CR32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jns.2012.06.018","volume":"320","author":"A Contreras","year":"2012","unstructured":"Contreras A, Grandas F (2012) Risk factors for freezing of gait in Parkinson\u2019s disease. J Neurol Sci 320(1\u20132):66\u201371","journal-title":"J Neurol Sci"},{"key":"1463_CR33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neubiorev.2005.03.024","volume":"30","author":"R Cools","year":"2006","unstructured":"Cools R (2006) Dopaminergic modulation of cognitive functionimplications for L-DOPA treatment in Parkinson\u2019s disease. Neurosci Biobehav Rev 30:1\u201323","journal-title":"Neurosci Biobehav Rev"},{"key":"1463_CR34","doi-asserted-by":"crossref","unstructured":"Cossu G, Ricchi V, Pileri M et al (2015) Levodopa\u2013carbidopa intrajejunal gel in advanced Parkinson disease with \u2018\u2018on\u2019\u2019 freezing of gait. Neurol Sci","DOI":"10.1007\/s10072-015-2234-x"},{"issue":"1","key":"1463_CR35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S1353-8020(03)00060-9","volume":"10","author":"E Cubo","year":"2003","unstructured":"Cubo E, Moore CG, Leurgans S, Goetz CG (2003) Wheeled and standard walkers in Parkinson\u2019s disease patients with gait freezing. Parkinsonism Relat Disord 10(1):9\u201314","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"1463_CR36","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1111\/j.1532-5415.1991.tb03627.x","volume":"39","author":"JL Cummings","year":"1991","unstructured":"Cummings JL (1991) Behavioral complications of drug treatment of Parkinson\u2019s disease. J Am Geriatr Soc 39(7):708\u2013716","journal-title":"J Am Geriatr Soc"},{"issue":"5","key":"1463_CR37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.parkreldis.2012.02.005","volume":"18","author":"M Danoudis","year":"2012","unstructured":"Danoudis M, Iansek R, Simpson P (2012) Freezing of gait in Parkinson\u2019s disease: further insights into pathophysiological mechanisms. Parkinsonism Relat Disord 18(5):543\u2013547","journal-title":"Parkinsonism Relat Disord"},{"issue":"15","key":"1463_CR38","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1002\/mds.23363","volume":"25","author":"G Deuschl","year":"2010","unstructured":"Deuschl G, Margraf N, Spuler S, Kupsch A, Schulz-schaeffer WJ (2010) Camptocormia and myopathy. Mov Disord 25(15):2689\u20132690","journal-title":"Mov Disord"},{"key":"1463_CR39","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1136\/jnnp.2006.099184","volume":"77","author":"R Djaldetti","year":"2006","unstructured":"Djaldetti R, Melamed E (2006) Camptocormia in Parkinson\u2019s disease: new insights. J Neurol Neurosurg Psychiatry 77:1205","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"1463_CR40","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.parkreldis.2010.08.010","volume":"17","author":"S Donovan","year":"2011","unstructured":"Donovan S, Lim C, Diaz N et al (2011) Laserlight cues for gait freezing in Parkinson\u2019s disease: an open-label study. Parkinsonism Relat Disord 17(4):240\u2013245","journal-title":"Parkinsonism Relat Disord"},{"key":"1463_CR41","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.neulet.2014.08.043","volume":"582","author":"D Doruk","year":"2014","unstructured":"Doruk D, Gray Z, Bravo GL, Pascual-Leone A, Fregni F (2014) Effects of tDCS on executive function in Parkinson\u2019s disease. Neurosci Lett 582:27\u201331","journal-title":"Neurosci Lett"},{"issue":"10","key":"1463_CR42","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1002\/mds.25098","volume":"27","author":"B Dubois","year":"2012","unstructured":"Dubois B, Tolosa E, Katzenschlager R et al (2012) Donepezil in Parkinson\u2019s disease dementia: a randomized, double-blind efficacy and safety study. Mov Disord 27(10):1230\u20131238","journal-title":"Mov Disord"},{"issue":"9","key":"1463_CR43","doi-asserted-by":"crossref","first-page":"e106561","DOI":"10.1371\/journal.pone.0106561","volume":"9","author":"KA Ehgoetz Martens","year":"2014","unstructured":"Ehgoetz Martens KA, Ellard CG, Almeida QJ (2014) Does anxiety cause freezing of gait in Parkinson\u2019s disease? PLoS One 9(9):e106561","journal-title":"PLoS One"},{"key":"1463_CR44","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1056\/NEJMoa041470","volume":"351","author":"M Emre","year":"2004","unstructured":"Emre M, Aarsland D, Albanese A et al (2004) Rivastigmine for dementia associated with Parkinson\u2019s disease. N Engl J Med 351:2509\u20132518","journal-title":"N Engl J Med"},{"issue":"12","key":"1463_CR45","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","volume":"22","author":"M Emre","year":"2007","unstructured":"Emre M, Aarsland D, Brown R et al (2007) Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease. Mov Disord 22(12):1689\u20131707","journal-title":"Mov Disord"},{"issue":"10","key":"1463_CR46","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1136\/jnnp.2011.240366","volume":"82","author":"JR Evans","year":"2011","unstructured":"Evans JR, Mason SL, Williams-Gray CH, Foltynie T, Brayne C, Robbins TW, Barker RA (2011) The natural history of treated Parkinson\u2019s disease in an incident, community based cohort. J Neurol Neurosurg Psychiatry 82(10):1112\u20131118","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"12","key":"1463_CR47","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.parkreldis.2014.09.023","volume":"20","author":"SA Factor","year":"2014","unstructured":"Factor SA, Scullin MK, Sollinger AB et al (2014) Freezing of gait subtypes have different cognitive correlates in Parkinson\u2019s disease. Parkinsonism Relat Disord 20(12):1359\u20131364","journal-title":"Parkinsonism Relat Disord"},{"key":"1463_CR48","first-page":"1","volume":"20","author":"LW Ferguson","year":"2015","unstructured":"Ferguson LW, Rajput AH, Rajput A (2015) Early-onset vs. late-onset parkinson\u2019s disease: a clinical-pathological study. Can J Neurol Sci 20:1\u20137","journal-title":"Can J Neurol Sci"},{"issue":"2","key":"1463_CR49","doi-asserted-by":"crossref","first-page":"S489","DOI":"10.1002\/mds.21975","volume":"23","author":"MU Ferraye","year":"2008","unstructured":"Ferraye MU, Deb\u00fb B, Pollak P (2008) Deep brain stimulation effect on freezing of gait. Mov Disord 23(2):S489\u2013S494","journal-title":"Mov Disord"},{"issue":"1","key":"1463_CR50","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/brain\/awp229","volume":"133","author":"MU Ferraye","year":"2010","unstructured":"Ferraye MU, Deb\u00fb B, Fraix V, Goetz L, Ardouin C, Yelnik J et al (2010) Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson\u2019s disease. Brain 133(1):205\u2013214","journal-title":"Brain"},{"issue":"12","key":"1463_CR51","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1503\/cmaj.060542","volume":"175","author":"F Ferreri","year":"2006","unstructured":"Ferreri F, Agbokou C, Gauthier S (2006) Recognition and management of neuropsychiatric complications in Parkinson\u2019s disease. CMAJ 175(12):1545\u20131552","journal-title":"CMAJ"},{"key":"1463_CR52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000314897","volume":"64","author":"J Finsterer","year":"2010","unstructured":"Finsterer J, Strobl W (2010) Presentation, etiology, diagnosis, and management of camptocormia. Eur Neurol 64:1\u20138","journal-title":"Eur Neurol"},{"issue":"23","key":"1463_CR53","doi-asserted-by":"crossref","first-page":"e140","DOI":"10.1212\/WNL.0b013e318239c081","volume":"77","author":"PB Foley","year":"2011","unstructured":"Foley PB (2011) Methylphenidate for gait impairment in Parkinson disease: a randomized clinical trial. Neurology 77(23):e140","journal-title":"Neurology"},{"issue":"7","key":"1463_CR54","first-page":"VII\/21","volume":"253","author":"K Fujimoto","year":"2006","unstructured":"Fujimoto K (2006) Dropped head in Parkinson\u2019s disease. J Neurol 253(7):VII\/21\u2013VII\/26","journal-title":"J Neurol"},{"issue":"2","key":"1463_CR55","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mehy.2012.11.031","volume":"80","author":"K Fukada","year":"2013","unstructured":"Fukada K, Endo T, Yokoe M, Hamasaki T, Hazama T, Sakoda S (2013) L-threo-3,4-dihydroxyphenylserine (L-DOPS) co-administered with entacapone improves freezing of gait in Parkinson\u2019s disease. Med Hypotheses 80(2):209\u2013212","journal-title":"Med Hypotheses"},{"key":"1463_CR56","doi-asserted-by":"crossref","first-page":"677","DOI":"10.3233\/JPD-140398","volume":"4","author":"C Gasca-Salas","year":"2014","unstructured":"Gasca-Salas C, Estanga S, Clavero P et al (2014) Longitudinal assesment of the pattern of cognitive decline in non-demented patients with advanced Parkinson\u2019s disease. J Parkinsons Dis 4:677\u2013686","journal-title":"J Parkinsons Dis"},{"key":"1463_CR57","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.parkreldis.2009.06.003","volume":"15","author":"HJ Gdynia","year":"2009","unstructured":"Gdynia HJ, Sperfeld AD, Unrath A, Ludolph AC, Sabolek M, Storch A, Kassubek J (2009) Histopathological analysis of skeletal muscle in patients with Parkinson\u2019s disease and \u2018dropped head\u2019\/\u2019bent spine\u2019 syndrome. Parkinsonism Relat Disord 15:633\u2013639","journal-title":"Parkinsonism Relat Disord"},{"issue":"2","key":"1463_CR58","doi-asserted-by":"crossref","first-page":"S482","DOI":"10.1002\/mds.21914","volume":"23","author":"N Giladi","year":"2008","unstructured":"Giladi N (2008) Medical treatment of freezing of gait. Mov Disord 23(2):S482\u2013S488","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"1463_CR59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jns.2006.05.015","volume":"248","author":"N Giladi","year":"2006","unstructured":"Giladi N, Hausdorff JM (2006) The role of mental function in the pathogenesis of freezing of gait in Parkinson\u2019s disease. J Neurol Sci 248(1\u20132):173\u2013176","journal-title":"J Neurol Sci"},{"key":"1463_CR60","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S1353-8020(99)00062-0","volume":"6","author":"N Giladi","year":"2000","unstructured":"Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD (2000) Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism Relat Disord 6:165\u2013170","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"1463_CR61","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1212\/WNL.56.12.1712","volume":"56","author":"N Giladi","year":"2001","unstructured":"Giladi N, Mcdermott MP, Fahn S et al (2001) Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 56(12):1712\u20131721","journal-title":"Neurology"},{"issue":"1","key":"1463_CR62","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1212\/01.WNL.0000148479.10865.FE","volume":"64","author":"CG Goetz","year":"2005","unstructured":"Goetz CG, Wuu J, Curgian LM, Leurgans S (2005) Hallucinations and sleep disorders in PD: six-year prospective longitudinal study. Neurology 64(1):81\u201386","journal-title":"Neurology"},{"issue":"11","key":"1463_CR63","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1345\/aph.1H587","volume":"41","author":"JJ Gugger","year":"2007","unstructured":"Gugger JJ, Wagner ML (2007) Rapid eye movement sleep behavior disorder. Ann Pharmacother 41(11):1833\u20131841","journal-title":"Ann Pharmacother"},{"issue":"6","key":"1463_CR64","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.parkreldis.2014.02.028","volume":"20","author":"JM Hall","year":"2014","unstructured":"Hall JM, Shine JM, Walton CC et al (2014) Early phenotypic differences between Parkinson\u2019s disease patients with and without freezing of gait. Parkinsonism Relat Disord 20(6):604\u2013607","journal-title":"Parkinsonism Relat Disord"},{"issue":"Suppl 2","key":"1463_CR65","doi-asserted-by":"crossref","first-page":"S439","DOI":"10.1002\/mds.21836","volume":"23","author":"M Hallett","year":"2008","unstructured":"Hallett M (2008) The intrinsic and extrinsic aspects of freezing of gait. Mov Disord 23(Suppl 2):S439\u2013S443","journal-title":"Mov Disord"},{"issue":"1","key":"1463_CR66","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3233\/JPD-130259","volume":"4","author":"RA Hauser","year":"2014","unstructured":"Hauser RA, Hewitt LA, Isaacson S (2014) Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson\u2019s disease (NOH306A). J Parkinsons Dis 4(1):57\u201365","journal-title":"J Parkinsons Dis"},{"issue":"6","key":"1463_CR67","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008) The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov Disord 23(6):837\u2013844","journal-title":"Mov Disord"},{"issue":"1","key":"1463_CR68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1136\/jnnp.53.1.39","volume":"53","author":"M Herrera-Marschitz","year":"1990","unstructured":"Herrera-Marschitz M, Utsumi H, Ungerstedt U (1990) Scoliosis in rats with experimentally-induced hemiparkinsonism: dependence upon striatal dopamine denervation. J Neurol Neurosurg Psychiatr 53(1):39\u201343","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"8","key":"1463_CR69","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/sleep\/25.8.62","volume":"25","author":"B H\u00f6gl","year":"2002","unstructured":"H\u00f6gl B, Saletu M, Brandauer E et al (2002) Modafinil for the treatment of daytime sleepiness in Parkinson\u2019s disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial. Sleep 25(8):905\u2013909","journal-title":"Sleep"},{"issue":"7","key":"1463_CR70","first-page":"1044","volume":"61","author":"RG Holloway","year":"2004","unstructured":"Holloway RG, Shoulson I, Fahn S et al (2004) Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch Neurol 61(7):1044\u20131053","journal-title":"Arch Neurol"},{"key":"1463_CR71","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.cortex.2015.05.014","volume":"69","author":"W Hsu","year":"2015","unstructured":"Hsu W, Zanto TP, Anguera JA, Lin Y, Gazzaley A (2015) Delayed enhancement of multitasking performance: effects of anodal transcranial direct current stimulation on the prefrontal cortex. Cortex 69:175\u2013185","journal-title":"Cortex"},{"issue":"2","key":"1463_CR72","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.expneurol.2008.10.019","volume":"215","author":"JV Jacobs","year":"2009","unstructured":"Jacobs JV, Nutt JG, Carlson-kuhta P, Stephens M, Horak FB (2009) Knee trembling during freezing of gait represents multiple anticipatory postural adjustments. Exp Neurol 215(2):334\u2013341","journal-title":"Exp Neurol"},{"issue":"5","key":"1463_CR73","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.toxicon.2008.11.013","volume":"54","author":"J Jankovic","year":"2009","unstructured":"Jankovic J (2009) Disease-oriented approach to botulinum toxin use. Toxicon 54(5):614\u2013623","journal-title":"Toxicon"},{"issue":"5","key":"1463_CR74","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/mds.23139","volume":"25","author":"J Jankovic","year":"2010","unstructured":"Jankovic J (2010) Camptocormia, head drop and other bent spine syndromes: heterogeneous etiology and pathogenesis of Parkinsonian deformities. Mov Disord 25(5):527\u2013528","journal-title":"Mov Disord"},{"issue":"9","key":"1463_CR75","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/mds.20974","volume":"21","author":"CC Janvin","year":"2006","unstructured":"Janvin CC, Larsen JP, Aarsland D, Hugdahl K (2006) Subtypes of mild cognitive impairment in Parkinson\u2019s disease: progression to dementia. Mov Disord 21(9):1343\u20131349","journal-title":"Mov Disord"},{"issue":"2","key":"1463_CR76","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.neuroimage.2014.08.016","volume":"102","author":"AH Javadi","year":"2014","unstructured":"Javadi AH, Brunec IK, Walsh V, Penny WD, Spiers HJ (2014) Transcranial electrical brain stimulation modulates neuronal tuning curves in perception of numerosity and duration. Neuroimage 102(2):451\u2013457","journal-title":"Neuroimage"},{"issue":"1","key":"1463_CR77","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1681\/ASN.V10135","volume":"10","author":"J Jordan","year":"1999","unstructured":"Jordan J, Shannon JR, Pohar B et al (1999) Contrasting effects of vasodilators on blood pressure and sodium balance in the hypertension of autonomic failure. J Am Soc Nephrol 10(1):35\u201342","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1463_CR78","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/mds.10620","volume":"19","author":"JL Juncos","year":"2004","unstructured":"Juncos JL, Roberts VJ, Evatt ML et al (2004) Quetiapine improves psychotic symptoms and cognition in Parkinson\u2019s disease. Mov Disord 19(1):29\u201335","journal-title":"Mov Disord"},{"issue":"10","key":"1463_CR79","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s00259-014-2796-5","volume":"41","author":"V Kaasinen","year":"2014","unstructured":"Kaasinen V, Kinos M, Joutsa J, Sepp\u00e4nen M, Noponen T (2014) Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson\u2019s disease. Eur J Nucl Med Mol Imaging 41(10):1931\u20131937","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"5","key":"1463_CR80","doi-asserted-by":"crossref","first-page":"382","DOI":"10.7326\/0003-4819-133-5-200009050-00014","volume":"133","author":"H Kaufmann","year":"2000","unstructured":"Kaufmann H (2000) Primary autonomic failure: three clinical presentations of one disease? Ann Intern Med 133(5):382\u2013384","journal-title":"Ann Intern Med"},{"issue":"12","key":"1463_CR81","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/S1474-4422(10)70212-X","volume":"9","author":"AA Kehagia","year":"2010","unstructured":"Kehagia AA, Barker RA, Robbins TW (2010) Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson\u2019s disease. Lancet Neurol 9(12):1200\u20131213","journal-title":"Lancet Neurol"},{"issue":"7","key":"1463_CR82","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1093\/brain\/awu117","volume":"137","author":"AA Kehagia","year":"2014","unstructured":"Kehagia AA, Housden CR, Regenthal R et al (2014) Targeting impulsivity in Parkinson\u2019s disease using atomoxetine. Brain 137(7):1986\u20131997","journal-title":"Brain"},{"issue":"14","key":"1463_CR83","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1212\/WNL.0b013e31824e8e96","volume":"78","author":"S Khan","year":"2012","unstructured":"Khan S, Gill SS, Mooney L, White P, Whone A, Brooks DJ et al (2012) Combined pedunculopontine subthalamic stimulation in Parkinson disease. Neurology 78(14):1090\u20131095","journal-title":"Neurology"},{"issue":"11","key":"1463_CR84","doi-asserted-by":"crossref","first-page":"e48890","DOI":"10.1371\/journal.pone.0048890","volume":"7","author":"YE Kim","year":"2012","unstructured":"Kim YE, Yun JY, Yang HJ et al (2012) Intravenous amantadine for freezing of gait resistant to dopaminergic therapy: a randomized, double-blind, placebo-controlled, cross-over clinical trial. PLoS ONE 7(11):e48890","journal-title":"PLoS ONE"},{"key":"1463_CR85","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1056\/NEJM198804073181402","volume":"318","author":"SJ Kish","year":"1988","unstructured":"Kish SJ, Shannak K, Hornykiewicz O (1988) Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson\u2019s disease. Pathophysiologic and clinical implications. N Engl J Med 318:876\u2013880","journal-title":"N Engl J Med"},{"key":"1463_CR86","doi-asserted-by":"crossref","first-page":"23","DOI":"10.17925\/ENR.2015.10.01.23","volume":"10","author":"Amos D Korczyn","year":"2015","unstructured":"Korczyn Amos D, Ray Chaudhuri K, van Laar Teus (2015) Extending our understanding of the dopaminergic basis of non-motor symptoms in Parkinson\u2019s disease. Eur Neurol Rev 10:23\u201327","journal-title":"Eur Neurol Rev"},{"issue":"4","key":"1463_CR87","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000113398","volume":"38","author":"P Lamberti","year":"1997","unstructured":"Lamberti P, Armenise S, Castaldo V, de Mari M et al (1997) Freezing gait in parkinson\u2019s disease. Eur Neurol 38(4):297\u2013301","journal-title":"Eur Neurol"},{"issue":"12","key":"1463_CR88","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1007\/s00415-013-7108-7","volume":"260","author":"JY Lee","year":"2013","unstructured":"Lee JY, Oh S, Kim JM et al (2013) Intravenous amantadine on freezing of gait in Parkinson\u2019s disease: a randomized controlled trial. J Neurol 260(12):3030\u20133038","journal-title":"J Neurol"},{"issue":"8","key":"1463_CR89","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s00586-010-1370-5","volume":"19","author":"T Lenoir","year":"2010","unstructured":"Lenoir T, Guedj N, Boulu P, Guigui P, Benoist M (2010) Camptocormia: the bent spine syndrome, an update. Eur Spine J 19(8):1229\u20131237","journal-title":"Eur Spine J"},{"issue":"5","key":"1463_CR90","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.parkreldis.2008.08.006","volume":"15","author":"SJ Lewis","year":"2009","unstructured":"Lewis SJ, Barker RA (2009) A pathophysiological model of freezing of gait in Parkinson\u2019s disease. Parkinsonism Relat Disord 15(5):333\u2013338","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"1463_CR91","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1136\/jnnp.66.3.289","volume":"66","author":"P Limousin","year":"1999","unstructured":"Limousin P, Speelman JD, Gielen F, Janssens M (1999) Multicentre European study of thalamic stimulation in parkinsonian and essential tremor. J Neurol Neurosurg Psychiatr 66(3):289\u2013296","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"10","key":"1463_CR92","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/mds.23823","volume":"26","author":"I Litvan","year":"2011","unstructured":"Litvan I, Aarsland D, Adler CH et al (2011) MDS task force on mild cognitive impairment in Parkinson\u2019s disease: critical review of PD-MCI. Mov Disord 26(10):1814\u20131824","journal-title":"Mov Disord"},{"issue":"14","key":"1463_CR93","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/mds.23280","volume":"25","author":"I Maidan","year":"2010","unstructured":"Maidan I, Plotnik M, Mirelman A, Weiss A, Giladi N, Hausdorff JM (2010) Heart rate changes during freezing of gait in patients with Parkinson\u2019s disease. Mov Disord 25(14):2346\u20132354","journal-title":"Mov Disord"},{"issue":"6","key":"1463_CR94","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/WNF.0b013e31826e3406","volume":"35","author":"R Malkani","year":"2012","unstructured":"Malkani R, Zadikoff C, Melen O, Videnovic A, Borushko E, Simuni T (2012) Amantadine for freezing of gait in patients with Parkinson disease. Clin Neuropharmacol 35(6):266\u2013268","journal-title":"Clin Neuropharmacol"},{"issue":"7","key":"1463_CR95","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/mds.26236","volume":"30","author":"E Mamikonyan","year":"2015","unstructured":"Mamikonyan E, Xie SX, Melvin E, Weintraub D (2015) Rivastigmine for mild cognitive impairment in Parkinson disease: a placebo-controlled study. Mov Disord 30(7):912\u2013918","journal-title":"Mov Disord"},{"key":"1463_CR96","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/mds.22780","volume":"25","author":"NG Margraf","year":"2010","unstructured":"Margraf NG, Wrede A, Rohr A, Schulz- Schaeffer WJ, Raethjen J, Eymess A, Volkmann J, Mehdorn MH, Jansen O, Deuschl G (2010) Camptocormia in idiopathic Parkinson\u2019s disease: a focal myopathy of the paravertebral muscles. Mov Disord 25:542\u2013551","journal-title":"Mov Disord"},{"key":"1463_CR97","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.resp.2013.03.008","volume":"187","author":"P Marinelli","year":"2013","unstructured":"Marinelli P, Colosimo C, Ferrazza AM, Di Stasio F, Fabbrini G, Palange P, Berardelli A (2013) Effect of camptocormia on lung volumes in Parkinson\u2019s disease. Respir Physiol Neurobiol 187:164\u2013166","journal-title":"Respir Physiol Neurobiol"},{"issue":"7","key":"1463_CR98","first-page":"VII\/14","volume":"253","author":"E Melamed","year":"2006","unstructured":"Melamed E, Djaldetti R (2006) Camptocormia in Parkinson\u2019s disease. J Neurol 253(7):VII\/14\u2013VII\/16","journal-title":"J Neurol"},{"issue":"14","key":"1463_CR99","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1002\/mds.21656","volume":"22","author":"DA Mendon\u00e7a","year":"2007","unstructured":"Mendon\u00e7a DA, Menezes K, Jog MS (2007) Methylphenidate improves fatigue scores in Parkinson disease: a randomized controlled trial. Mov Disord 22(14):2070\u20132076","journal-title":"Mov Disord"},{"issue":"8","key":"1463_CR100","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1001\/archgenpsychiatry.2009.106","volume":"66","author":"PM Meyer","year":"2009","unstructured":"Meyer PM, Strecker K, Kendziorra K et al (2009) Reduced alpha4beta2*-nicotinic acetylcholine receptor binding and its relationship to mild cognitive and depressive symptoms in Parkinson disease. Arch Gen Psychiatry 66(8):866\u2013877","journal-title":"Arch Gen Psychiatry"},{"issue":"7","key":"1463_CR101","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1212\/01.wnl.0000215428.46057.3d","volume":"66","author":"JM Miyasaki","year":"2006","unstructured":"Miyasaki JM, Shannon K, Voon V et al (2006) Practice parameter: evaluation and treatment of depression, psychosis, and dementia in Parkinson disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 66(7):996\u20131002","journal-title":"Neurology"},{"issue":"2","key":"1463_CR102","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1177\/1545968314545175","volume":"29","author":"F Mohammadi","year":"2015","unstructured":"Mohammadi F, Bruijn SM, Vervoort G, van Wegen EE, Kwakkel G, Verschueren S, Nieuwboer A (2015) Motor switching and motor adaptation deficits contribute to freezing of gait in parkinson\u2019s disease. Neurorehabil Neural Repair 29(2):132\u2013142","journal-title":"Neurorehabil Neural Repair"},{"issue":"4","key":"1463_CR103","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/mds.20342","volume":"20","author":"FS Monte","year":"2005","unstructured":"Monte FS, da Silva-J\u00fanior FP, Braga-Neto P, Nobre e Souza MA, de Bruin VM (2005) Swallowing abnormalities and dyskinesia in Parkinson\u2019s disease. Mov Disord 20(4):457\u2013462","journal-title":"Mov Disord"},{"key":"1463_CR104","author":"ST Moore","year":"2013","unstructured":"Moore ST, Yungher DA, Morris TR, Dilda V, MacDougall HG, Shine JM, Naismith SL, Lewis SJG (2013) Autonomous identification of freezing of gait in Parkinson\u2019s disease from lower-body segmental accelerometry. J Neuroeng Rehabil. doi: 10.1186\/1743-0003-10-19","journal-title":"J Neuroeng Rehabil"},{"issue":"7","key":"1463_CR105","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S1474-4422(12)70106-0","volume":"11","author":"C Moreau","year":"2012","unstructured":"Moreau C, Delval A, Defebvre L et al (2012) Methylphenidate for gait hypokinesia and freezing in patients with Parkinson\u2019s disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial. Lancet Neurol 11(7):589\u2013596","journal-title":"Lancet Neurol"},{"issue":"10","key":"1463_CR106","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2522\/ptj.20050277","volume":"86","author":"ME Morris","year":"2006","unstructured":"Morris ME (2006) Locomotor training in people with Parkinson disease. Phys Ther 86(10):1426\u20131435","journal-title":"Phys Ther"},{"key":"1463_CR107","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.gaitpost.2012.12.011","volume":"38","author":"TR Morris","year":"2013","unstructured":"Morris TR, Cho C, Dilda V, Shine JM, Naismith SL, Lewis SJ, Moore ST (2013) Clinical assessment of freezing of gait in Parkinson\u2019s disease from computer-generated animation. Gait Posture 38:326\u2013329","journal-title":"Gait Posture"},{"key":"1463_CR108","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.neuroscience.2011.02.061","volume":"182","author":"W Nanhoe-Mahabier","year":"2011","unstructured":"Nanhoe-Mahabier W, Snijders AH, Delval A et al (2011) Walking patterns in Parkinson\u2019s disease with and without freezing of gait. Neuroscience 182:217\u2013224","journal-title":"Neuroscience"},{"issue":"Suppl 2","key":"1463_CR109","doi-asserted-by":"crossref","first-page":"S475","DOI":"10.1002\/mds.21978","volume":"23","author":"A Nieuwboer","year":"2008","unstructured":"Nieuwboer A (2008) Cueing for freezing of gait in patients with Parkinson\u2019s disease: a rehabilitation perspective. Mov Disord 23(Suppl 2):S475\u2013S481","journal-title":"Mov Disord"},{"issue":"11","key":"1463_CR110","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1002\/mds.25683","volume":"28","author":"A Nieuwboer","year":"2013","unstructured":"Nieuwboer A, Giladi N (2013) Characterizing freezing of gait in Parkinson\u2019s disease: models of an episodic phenomenon. Mov Disord 28(11):1509\u20131519","journal-title":"Mov Disord"},{"issue":"7","key":"1463_CR111","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1111\/j.1460-9568.2009.06681.x","volume":"29","author":"A Nieuwboer","year":"2009","unstructured":"Nieuwboer A, Vercruysse S, Feys P, Levin O, Spildooren J, Swinnen S (2009) Upper limb movement interruptions are correlated to freezing of gait in Parkinson\u2019s disease. Eur J Neurosci 29(7):1422\u20131430","journal-title":"Eur J Neurosci"},{"issue":"3","key":"1463_CR112","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1177\/147323001204000330","volume":"40","author":"L Niu","year":"2012","unstructured":"Niu L, Ji LY, Li JM et al (2012) Effect of bilateral deep brain stimulation of the subthalamic nucleus on freezing of gait in Parkinson\u2019s disease. J Int Med Res 40(3):1108\u20131113","journal-title":"J Int Med Res"},{"issue":"7","key":"1463_CR113","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S1474-4422(15)00041-1","volume":"14","author":"J Nonnekes","year":"2015","unstructured":"Nonnekes J, Snijders AH, Nutt JG, Deuschl G, Giladi N, Bloem BR (2015) Freezing of gait: a practical approach to management. Lancet Neurol 14(7):768\u2013778","journal-title":"Lancet Neurol"},{"issue":"1","key":"1463_CR114","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ccl.2012.09.003","volume":"31","author":"VC Nwazue","year":"2013","unstructured":"Nwazue VC, Raj SR (2013) Confounders of vasovagal syncope: orthostatic hypotension. Cardiol Clin 31(1):89\u2013100","journal-title":"Cardiol Clin"},{"key":"1463_CR115","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/ana.24011","volume":"74","author":"CW Olanow","year":"2013","unstructured":"Olanow CW, Schapira AHV (2013) Therapeutic prospects for Parkinson disease. Ann Neurol. 74:337\u2013347","journal-title":"Ann Neurol."},{"issue":"14","key":"1463_CR116","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1212\/01.wnl.0000258660.74391.c1","volume":"68","author":"R Pahwa","year":"2007","unstructured":"Pahwa R, Stacy MA, Factor SA et al (2007) Ropinirole 24-hour prolonged release: randomized, controlled study in advanced Parkinson disease. Neurology 68(14):1108\u20131115","journal-title":"Neurology"},{"issue":"5","key":"1463_CR117","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1001\/jamaneurol.2013.2110","volume":"70","author":"KF Pedersen","year":"2013","unstructured":"Pedersen KF, Larsen JP, Tysnes OB, Alves G (2013) Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study. JAMA Neurol 70(5):580\u2013586","journal-title":"JAMA Neurol"},{"issue":"6","key":"1463_CR118","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jalz.2011.09.230","volume":"8","author":"F Perez","year":"2012","unstructured":"Perez F, Helmer C, Foubert-Samier A, Auriacombe S, Dartigues JF, Tison F (2012) Risk of dementia in an elderly population of Parkinson\u2019s disease patients: a 15-year population-based study. Alzheimers Dement 8(6):463\u2013469","journal-title":"Alzheimers Dement"},{"issue":"4","key":"1463_CR119","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1517\/14656561003598919","volume":"11","author":"G Pezzoli","year":"2010","unstructured":"Pezzoli G, Zini M (2010) Levodopa in Parkinson\u2019s disease: from the past to the future. Expert Opin Pharmacother 11(4):627\u2013635","journal-title":"Expert Opin Pharmacother"},{"key":"1463_CR120","first-page":"459321","volume":"2012","author":"M Plotnik","year":"2012","unstructured":"Plotnik M, Giladi N, Hausdorff JM (2012) Is freezing of gait in Parkinson\u2019s disease a result of multiple gait impairments? Implications for treatment. Parkinsons Dis 2012:459321","journal-title":"Parkinsons Dis"},{"issue":"5","key":"1463_CR121","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/jnnp.2003.029868","volume":"75","author":"P Pollak","year":"2004","unstructured":"Pollak P, Tison F, Rascol O et al (2004) Clozapine in drug induced psychosis in Parkinson\u2019s disease: a randomised, placebo controlled study with open follow up. J Neurol Neurosurg Psychiatr 75(5):689\u2013695","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"5","key":"1463_CR122","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1159\/000324372","volume":"8","author":"M Ponfick","year":"2011","unstructured":"Ponfick M, Gdynia HJ, Ludolph AC, Kassubek J (2011) Camptocormia in Parkinson\u2019s disease: a review of the literature. Neurodegener Dis 8(5):283\u2013288","journal-title":"Neurodegener Dis"},{"key":"1463_CR123","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1056\/NEJM200005183422004","volume":"342","author":"O Rascol","year":"2000","unstructured":"Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE, For the 056 Study Group (2000) A five-year study of the incidence of dyskinesia in patients with early parkinson\u2019s disease who were treated with ropinirole or levodopa. New Engl J Med 342:1484\u20131491","journal-title":"New Engl J Med"},{"key":"1463_CR124","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S0140-6736(05)71083-7","volume":"365","author":"O Rascol","year":"2005","unstructured":"Rascol O, Brooks DJ, Melamed E et al (2005) Rasagiline as an adjunct to levodopa in patients with Parkinson\u2019s disease and motor fl uctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial. Lancet 365:947\u2013954","journal-title":"Lancet"},{"issue":"7","key":"1463_CR125","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1136\/jnnp.2004.050682","volume":"76","author":"B Ravina","year":"2005","unstructured":"Ravina B, Putt M, Siderowf A et al (2005) Donepezil for dementia in Parkinson\u2019s disease: a randomised, double blind, placebo controlled, crossover study. J Neurol Neurosurg Psychiatr 76(7):934\u2013939","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"1\u20132","key":"1463_CR126","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jns.2014.03.023","volume":"340","author":"GJ Revuelta","year":"2014","unstructured":"Revuelta GJ, Montilla J, Benatar M et al (2014) An 18F-FDG PET study of cervical muscle in parkinsonian anterocollis. J Neurol Sci 340(1\u20132):174\u2013177","journal-title":"J Neurol Sci"},{"key":"1463_CR127","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/1752-1947-4-192","volume":"4","author":"F Robert","year":"2010","unstructured":"Robert F, Koenig M, Robert A, Boyer S, Cathebras P, Camdessanche JP (2010) Acute camptocormia induced by olanzapine: a case report. J Med Case Rep 4:192","journal-title":"J Med Case Rep"},{"key":"1463_CR128","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.brainres.2010.03.029","volume":"1341","author":"JA Russell","year":"2010","unstructured":"Russell JA, Ciucci MR, Connor NP, Schallert T (2010) Targeted exercise therapy for voice and swallow in persons with Parkinson\u2019s disease. Brain Res 1341:3\u201311","journal-title":"Brain Res"},{"key":"1463_CR129","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.3171\/2010.3.JNS09981","volume":"113","author":"DE Sakas","year":"2010","unstructured":"Sakas DE, Panourias IG, Stavrinou LC, Boviatsis EJ, Themistocleous M, Stathis P et al (2010) Restoration of erect posture in idiopathic camptocormia by electrical stimulation of the globus pallidus internus. J Neurosurg 113:1246\u20131250","journal-title":"J Neurosurg"},{"issue":"7","key":"1463_CR130","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/mds.22529","volume":"24","author":"W Sako","year":"2009","unstructured":"Sako W, Nishio M, Maruo T, Shimazu H, Matsuzaki K, Tamura T, Mure H, Ushio Y, Nagahiro S, Kaji R, Goto S (2009) Subthalamic nucleus\u00a0deep\u00a0brain\u00a0stimulation\u00a0for\u00a0camptocormia\u00a0associated with\u00a0Parkinson\u2019s disease. Mov Disord 24(7):1076\u20131079","journal-title":"Mov Disord"},{"key":"1463_CR131","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jns.2006.05.028","volume":"248","author":"G Sammer","year":"2006","unstructured":"Sammer G, Reuter I, Hullmann K, Kaps M, Vaitl D (2006) Training of executive functions in Parkinson\u2019s disease. J Neurol Sci 248:115\u2013119","journal-title":"J Neurol Sci"},{"issue":"6","key":"1463_CR132","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1586\/ern.11.43","volume":"11","author":"S Sapir","year":"2011","unstructured":"Sapir S, Ramig LO, Fox CM (2011) Intensive voice treatment in Parkinson\u2019s disease: Lee Silverman Voice Treatment. Expert Rev Neurother 11(6):815\u2013830","journal-title":"Expert Rev Neurother"},{"issue":"8","key":"1463_CR133","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.parkreldis.2014.04.024","volume":"20","author":"M Saxena","year":"2014","unstructured":"Saxena M, Behari M, Kumaran SS, Goyal V, Narang V (2014) Assessing speech dysfunction using BOLD and acoustic analysis in parkinsonism. Parkinsonism Relat Disord 20(8):855\u2013861","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"1463_CR134","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1046\/j.1468-1331.2003.00611.x","volume":"10","author":"JD Schaafsma","year":"2003","unstructured":"Schaafsma JD, Balash Y, Gurevich T, Bartels AL, Hausdorff JM, Giladi N (2003) Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson\u2019s disease. Eur J Neurol 10(4):391\u2013398","journal-title":"Eur J Neurol"},{"issue":"3","key":"1463_CR135","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/mds.26081","volume":"30","author":"WJ Schulz-Schaeffer","year":"2015","unstructured":"Schulz-Schaeffer WJ, Margraf NG, Munser S, Wrede A, Buhmann C, Deuschl G, Oehlwein C (2015) Effect of neurostimulation on\u00a0camptocormia\u00a0in\u00a0Parkinson\u2019s disease depends on symptom duration. Mov Disord 30(3):368\u2013372. doi: 10.1002\/mds.2608","journal-title":"Mov Disord"},{"issue":"Suppl 3","key":"1463_CR136","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1002\/mds.23884","volume":"26","author":"K Seppi","year":"2011","unstructured":"Seppi K, Weintraub D, Coelho M et al (2011) The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson\u2019s disease. Mov Disord 26(Suppl 3):S42\u2013S80","journal-title":"Mov Disord"},{"issue":"4","key":"1463_CR137","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/mds.25301","volume":"28","author":"LC Shih","year":"2013","unstructured":"Shih LC, Vanderhorst VG, Lozano AM, Hamani C, Moro E (2013) Improvement of pisa syndrome with contralateral pedunculopontine stimulation. Mov Disord 28(4):555\u2013556","journal-title":"Mov Disord"},{"key":"1463_CR138","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.parkreldis.2011.08.002","volume":"18","author":"JM Shine","year":"2012","unstructured":"Shine JM, Moore ST, Bolitho SJ, Morris TR, Dilda V, Naismith SL, Lewis SJG (2012) Assessing the utility of Freezing of Gait Questionnaires in Parkinson\u2019s Disease. Parkinsonism Relat. Disord 18:25\u201329","journal-title":"Parkinsonism Relat. Disord"},{"issue":"1","key":"1463_CR139","doi-asserted-by":"crossref","first-page":"e52602","DOI":"10.1371\/journal.pone.0052602","volume":"8","author":"JM Shine","year":"2013","unstructured":"Shine JM, Matar E, Ward PB et al (2013) Differential neural activation patterns in patients with Parkinson\u2019s disease and freezing of gait in response to concurrent cognitive and motor load. pLoS one 8(1):e52602","journal-title":"pLoS one"},{"key":"1463_CR140","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/mds.22913","volume":"25","author":"S Spuler","year":"2010","unstructured":"Spuler S, Krug H, Klein C, Medialdea IC, Jakob W, Ebersbach G, Gruber D, Hoffmann K-T, Trottenberg T, Kupsch A (2010) Myopathy causing camptocormia in idiopathic Parkinson\u2019s disease: a multidisciplinary approach. Mov Disord 25:552\u2013559","journal-title":"Mov Disord"},{"key":"1463_CR141","doi-asserted-by":"crossref","unstructured":"Srivanitchapoom P, Hallett M (2015) Camptocormia in Parkinson\u2019s disease: definition, epidemiology, pathogenesis and treatment modalities. J Neurol Neurosurg Psychiatry pii:jnnp-2014-310049. doi: 10.1136\/jnnp-2014-310049 . [Epub ahead of print]","DOI":"10.1136\/jnnp-2014-310049"},{"key":"1463_CR142","first-page":"1109","volume":"20","author":"P Srivanitchapoom","year":"2014","unstructured":"Srivanitchapoom P et al (2014) Drooling in parkinson\u2019s disease: a review, parkinsonism relat. Disord 20:1109\u20131118","journal-title":"Disord"},{"issue":"6","key":"1463_CR143","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/brain\/awl346","volume":"130","author":"A Stefani","year":"2007","unstructured":"Stefani A, Lozano AM, Peppe A, Stanzione P, Galati S, Tropepi D et al (2007) Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson\u2019s disease. Brain 130(6):1596\u20131607","journal-title":"Brain"},{"issue":"1","key":"1463_CR144","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.expneurol.2008.09.022","volume":"215","author":"JF Stein","year":"2009","unstructured":"Stein JF (2009) Akinesia, motor oscillations and the pedunculopontine nucleus in rats and men. Exp Neurol 215(1):1\u20134","journal-title":"Exp Neurol"},{"issue":"14","key":"1463_CR145","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1002\/mds.23290","volume":"25","author":"HY Sung","year":"2010","unstructured":"Sung HY, Kim JS, Lee KS et al (2010) The prevalence and patterns of pharyngoesophageal dysmotility in patients with early stage Parkinson\u2019s disease. Mov Disord 25(14):2361\u20132368","journal-title":"Mov Disord"},{"issue":"1\u20132","key":"1463_CR146","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jns.2014.08.003","volume":"346","author":"MK Sunwoo","year":"2014","unstructured":"Sunwoo MK, Hong JY, Lee JE, Lee HS, Lee PH, Sohn YH (2014) Depression and voice handicap in Parkinson disease. J Neurol Sci 346(1\u20132):112\u2013115","journal-title":"J Neurol Sci"},{"issue":"11","key":"1463_CR147","first-page":"1193","volume":"62","author":"N Takezawa","year":"2010","unstructured":"Takezawa N, Mizuno T, Seo K, Kondo M, Nakagawa M (2010) Gait disturbances related to dysfunction of the cerebral cortex and basal ganglia. Brain Nerve 62(11):1193\u20131202","journal-title":"Brain Nerve"},{"issue":"2","key":"1463_CR148","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/mds.23930","volume":"27","author":"C Tassorelli","year":"2012","unstructured":"Tassorelli C, Furnari A, Buscone S et al (2012) Pisa syndrome in Parkinson\u2019s disease: clinical, electromyographic, and radiological characterization. Mov Disord 27(2):227\u2013235","journal-title":"Mov Disord"},{"key":"1463_CR149","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jnnp.2008.150011","volume":"80","author":"D Tiple","year":"2009","unstructured":"Tiple D, Fabbrini G, Colosimo C, Ottaviani D, Camerota F, Defazio G, Berardelli A (2009) Camptocormia in Parkinson\u2019s disease: an epidemiological and clinical study. J Neurol Neurosurg Psychiatry 80:145\u2013148","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"1463_CR150","first-page":"VII\/7","volume":"253","author":"E Tolosa","year":"2006","unstructured":"Tolosa E, Compta Y (2006) Dystonia in Parkinson\u2019s disease. J Neurol 253(7):VII\/7\u2013VII\/13","journal-title":"J Neurol"},{"key":"1463_CR151","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/mds.23441","volume":"26","author":"C Trenkwalder","year":"2011","unstructured":"Trenkwalder C et al (2011) Rotigotine effects on early morning motor function and sleep in Parkinson\u2019s disease: A double-blind, randomized, placebo-controlled study (RECOVER). Mov Disord 26:90\u201399","journal-title":"Mov Disord"},{"issue":"6","key":"1463_CR152","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.3171\/2009.10.JNS09917","volume":"112","author":"A Umemura","year":"2010","unstructured":"Umemura A, Oka Y, Ohkita K, Yamawaki T, Yamada K (2010) Effect of subthalamic\u00a0deep\u00a0brain\u00a0stimulation\u00a0on postural abnormality in\u00a0Parkinson\u00a0disease. J Neurosurg 112(6):1283\u20131288","journal-title":"J Neurosurg"},{"issue":"2","key":"1463_CR153","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/0006-8993(69)90122-X","volume":"14","author":"U Ungerstedt","year":"1969","unstructured":"Ungerstedt U, Butcher LL, Butcher SG, And\u00e9n NE, Fuxe K (1969) Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat. Brain Res 14(2):461\u2013471","journal-title":"Brain Res"},{"issue":"14","key":"1463_CR154","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1002\/mds.25687","volume":"28","author":"DE Vaillancourt","year":"2013","unstructured":"Vaillancourt DE, Schonfeld D, Kwak Y, Bohnen NI, Seidler R (2013) Dopamine overdose hypothesis: evidence and clinical implications. Mov Disord 28(14):1920\u20131929","journal-title":"Mov Disord"},{"key":"1463_CR155","first-page":"356","volume":"6","author":"J Vandenbossche","year":"2012","unstructured":"Vandenbossche J, Deroost N, Soetens E et al (2012) Freezing of gait in Parkinson\u2019s disease: disturbances in automaticity and control. Front Hum Neurosci 6:356","journal-title":"Front Hum Neurosci"},{"issue":"4","key":"1463_CR156","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1212\/01.wnl.0000266593.50534.e8","volume":"69","author":"D Verbaan","year":"2007","unstructured":"Verbaan D, Marinus J, Visser M, Van rooden SM, Stiggelbout AM, Van hilten JJ (2007) Patient-reported autonomic symptoms in Parkinson disease. Neurology 69(4):333\u2013341","journal-title":"Neurology"},{"key":"1463_CR157","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1002\/mds.25183","volume":"27","author":"S Vercruysse","year":"2012","unstructured":"Vercruysse S, Devos H, Munks L, Spildooren J, Vandenbossche J, Vandenberghe W, Nieuwboer A, Heremans E (2012a) Explaining freezing of gait in Parkinson\u2019s disease: motor and cognitive determinants. Mov Disord 27:1644\u20131651","journal-title":"Mov Disord"},{"key":"1463_CR158","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/mds.24015","volume":"27","author":"S Vercruysse","year":"2012","unstructured":"Vercruysse S, Spildooren J, Heremans E, Vandenbossche J, Levin O, Wenderoth N, Swinnen SP, Janssens L, Vandenberghe W, Nieuwboer A (2012b) Freezing in Parkinson\u2019s disease: a spatiotemporal motor disorder beyond gait. Mov. Disord 27:254\u2013263. doi: 10.1002\/mds.24015","journal-title":"Mov. Disord"},{"issue":"8","key":"1463_CR159","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1002\/mds.23657","volume":"26","author":"C Vitale","year":"2011","unstructured":"Vitale C, Marcelli V, Furia T et al (2011) Vestibular impairment and adaptive postural imbalance in parkinsonian patients with lateral trunk flexion. Mov Disord 26(8):1458\u20131463","journal-title":"Mov Disord"},{"issue":"2","key":"1463_CR160","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1136\/jnnp-2014-307659","volume":"86","author":"HF Wang","year":"2015","unstructured":"Wang HF, Yu JT, Tang SW et al (2015) Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson\u2019s disease, Parkinson\u2019s disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis. J Neurol Neurosurg Psychiatr 86(2):135\u2013143","journal-title":"J Neurol Neurosurg Psychiatr"},{"issue":"5","key":"1463_CR161","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1212\/WNL.0b013e3181ebdd79","volume":"75","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Mavandadi S, Mamikonyan E et al (2010) Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology 75(5):448\u2013455","journal-title":"Neurology"},{"issue":"11","key":"1463_CR162","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1136\/jnnp.2010.213462","volume":"82","author":"RA Wilcox","year":"2011","unstructured":"Wilcox RA et al (2011) Pedunculopontine nucleus deep brain stimulation produces sustained improvement in primary progressive freezing of gait. J Neurol Neurosurg Psychiatry 82(11):1256\u20131259","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1463_CR163","first-page":"595378","volume":"2013","author":"AJ Williams","year":"2013","unstructured":"Williams AJ, Peterson DS, Ionno M, Pickett KA, Earhart GM (2013) Upper extremity freezing and dyscoordination in Parkinson\u2019s disease: effects of amplitude and cadence manipulations. Parkinsons Dis 2013:595378","journal-title":"Parkinsons Dis"},{"issue":"7","key":"1463_CR164","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/brain\/awm111","volume":"130","author":"CH Williams-Gray","year":"2007","unstructured":"Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA (2007) Evolution of cognitive dysfunction in an incident Parkinson\u2019s disease cohort. Brain 130(7):1787\u20131798","journal-title":"Brain"},{"issue":"11","key":"1463_CR165","doi-asserted-by":"crossref","first-page":"2958","DOI":"10.1093\/brain\/awp245","volume":"132","author":"CH Williams-Gray","year":"2009","unstructured":"Williams-Gray CH, Evans JR, Goris A et al (2009) The distinct cognitive syndromes of Parkinson\u2019s disease: 5\u00a0year follow-up of the CamPaIGN cohort. Brain 132(11):2958\u20132969","journal-title":"Brain"},{"key":"1463_CR166","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","volume":"84","author":"CH Williams-Gray","year":"2013","unstructured":"Williams-Gray CH, Mason SL, Evans JR et al (2013) The CamPaIGN study of Parkinson\u2019s disease: 10-year outlook in an incident population-based cohort. J Neurol Neurosurg Psychiatry 84:1258\u20131264","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"1463_CR167","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/archneurol.2011.2370","volume":"69","author":"AW Willis","year":"2012","unstructured":"Willis AW, Schootman M, Kung N, Evanoff BA, Perlmutter JS, Racette BA (2012) Predictors of survival in patients with Parkinson disease. Arch Neurol 69(5):601\u2013607","journal-title":"Arch Neurol"},{"issue":"7","key":"1463_CR168","first-page":"17","volume":"253","author":"F Yokochi","year":"2006","unstructured":"Yokochi F (2006) Lateral flexion in Parkinson\u2019s disease and Pisa syndrome. J Neurol 253(7):17\u201320","journal-title":"J Neurol"}],"container-title":["Journal of Neural Transmission"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-015-1463-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00702-015-1463-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00702-015-1463-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T05:31:42Z","timestamp":1653197502000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00702-015-1463-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,26]]},"references-count":169,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["1463"],"URL":"https:\/\/doi.org\/10.1007\/s00702-015-1463-8","relation":{},"ISSN":["0300-9564","1435-1463"],"issn-type":[{"value":"0300-9564","type":"print"},{"value":"1435-1463","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,26]]}}}